The Role and Mechanism of Protein Post‑Translational Modification in Rheumatoid Arthritis

Jianting Wen,1– 3 Jian Liu,1– 3 Lei Wan,1– 3 Fanfan Wang2,3 1Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China; 2Institute of Rheumatology, Anhui Academy of Chinese Medicine, Hefei, Anhui Province, 230012, People’s Republic of China; 3Anhui Province Key Laboratory of Modern Chinese Medicine Department of Internal Medicine Application Foundation Research and Development, Hefei, Anhui, 230031, People’s Republic of ChinaCorrespondence: Jian Liu, Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China, Tel +86 0551 62838582, Fax +86 0551 62821605, Email [email protected]: Rheumatoid arthritis (RA) is a chronic autoimmune disease that significantly compromises patient quality of life due to its high prevalence and risk of disability. While its etiology remains incompletely understood, increasing evidence highlights the critical involvement of epigenetic mechanisms, particularly post-translational modifications (PTMs), in RA pathogenesis. Advances in proteomics have identified various PTMs—including phosphorylation, methylation, acetylation, ubiquitination, glycosylation, lactylation, as well as citrullination and carbamylation—as key regulators of inflammation, immune response, and tissue remodeling in RA. Importantly, dysregulated PTMs may alter protein structure and function, thereby contributing to disease progression. This review systematically summarizes current knowledge on the roles and mechanisms of major PTMs in RA, with a special focus on the cross-talk between PTMs, their interaction with non-coding RNAs, and the emerging therapeutic potential of traditional Chinese medicine (TCM) targeting PTMs. These insights may provide novel perspectives for the diagnosis and treatment of RA.Keywords: protein post-translational modification, rheumatoid arthritis, methylation, acetylation, lactylation

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-07-11
Primary Topic
Magnetic confinement fusion research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role and Mechanism of Protein Post‑Translational Modification in Rheumatoid Arthritis

Dove Medical Press (Taylor and Francis Group)
Magnetic confinement fusion research
article

The Role and Mechanism of Protein Post‑Translational Modification in Rheumatoid Arthritis

article en

Abstract

Jianting Wen,1– 3 Jian Liu,1– 3 Lei Wan,1– 3 Fanfan Wang2,3 1Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China; 2Institute of Rheumatology, Anhui Academy of Chinese Medicine, Hefei, Anhui Province, 230012, People’s Republic of China; 3Anhui Province Key Laboratory of Modern Chinese Medicine Department of Internal Medicine Application Foundation Research and Development, Hefei, Anhui, 230031, People’s Republic of ChinaCorrespondence: Jian Liu, Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China, Tel +86 0551 62838582, Fax +86 0551 62821605, Email [email protected]: Rheumatoid arthritis (RA) is a chronic autoimmune disease that significantly compromises patient quality of life due to its high prevalence and risk of disability. While its etiology remains incompletely understood, increasing evidence highlights the critical involvement of epigenetic mechanisms, particularly post-translational modifications (PTMs), in RA pathogenesis. Advances in proteomics have identified various PTMs—including phosphorylation, methylation, acetylation, ubiquitination, glycosylation, lactylation, as well as citrullination and carbamylation—as key regulators of inflammation, immune response, and tissue remodeling in RA. Importantly, dysregulated PTMs may alter protein structure and function, thereby contributing to disease progression. This review systematically summarizes current knowledge on the roles and mechanisms of major PTMs in RA, with a special focus on the cross-talk between PTMs, their interaction with non-coding RNAs, and the emerging therapeutic potential of traditional Chinese medicine (TCM) targeting PTMs. These insights may provide novel perspectives for the diagnosis and treatment of RA.Keywords: protein post-translational modification, rheumatoid arthritis, methylation, acetylation, lactylation

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 59%
Magnetic confinement fusion research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Role and Mechanism of Protein Post‑Translational Modification in Rheumatoid Arthritis · Dove Medical Press (Taylor and Francis Group) (2025) | TGRS Research Map | TGRS